
### [NCIT:C91244](http://purl.obolibrary.org/obo/NCIT_C91244)
**Label:** Nasopharyngeal Carcinoma by AJCC v7 Stage

**Subclasses:** [NCIT:C8229](http://purl.obolibrary.org/obo/NCIT_C8229) (Stage IV Nasopharyngeal Undifferentiated Carcinoma AJCC v7), [NCIT:C8227](http://purl.obolibrary.org/obo/NCIT_C8227) (Stage III Nasopharyngeal Undifferentiated Carcinoma AJCC v7), [NCIT:C8228](http://purl.obolibrary.org/obo/NCIT_C8228) (Stage IV Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7), [NCIT:C8225](http://purl.obolibrary.org/obo/NCIT_C8225) (Stage II Nasopharyngeal Undifferentiated Carcinoma AJCC v7), [NCIT:C6035](http://purl.obolibrary.org/obo/NCIT_C6035) (Stage 0 Nasopharyngeal Undifferentiated Carcinoma AJCC v6, v7, and v8), [NCIT:C8226](http://purl.obolibrary.org/obo/NCIT_C8226) (Stage III Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7), [NCIT:C8223](http://purl.obolibrary.org/obo/NCIT_C8223) (Stage I Nasopharyngeal Undifferentiated Carcinoma AJCC v7), [NCIT:C6036](http://purl.obolibrary.org/obo/NCIT_C6036) (Stage 0 Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v6, v7, and v8), [NCIT:C8224](http://purl.obolibrary.org/obo/NCIT_C8224) (Stage II Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7), [NCIT:C8222](http://purl.obolibrary.org/obo/NCIT_C8222) (Stage I Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7), [NCIT:C9099](http://purl.obolibrary.org/obo/NCIT_C9099) (Stage 0 Nasopharyngeal Carcinoma AJCC v6, v7, and v8), [NCIT:C88983](http://purl.obolibrary.org/obo/NCIT_C88983) (Stage III Nasopharyngeal Carcinoma AJCC v7), [NCIT:C88982](http://purl.obolibrary.org/obo/NCIT_C88982) (Stage II Nasopharyngeal Carcinoma AJCC v7), [NCIT:C88981](http://purl.obolibrary.org/obo/NCIT_C88981) (Stage I Nasopharyngeal Carcinoma AJCC v7), [NCIT:C88984](http://purl.obolibrary.org/obo/NCIT_C88984) (Stage IV Nasopharyngeal Carcinoma AJCC v7), 

**Class expressions from DL-Learner:**

- Thing 53.84%
- [NCIT:C90530](http://purl.obolibrary.org/obo/NCIT_C90530) (AJCC v7 Stage) 52.17%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) 37.53%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40175](http://purl.obolibrary.org/obo/NCIT_C40175) (Uterine Corpus Myxoid Leiomyosarcoma))) 37.53%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40174](http://purl.obolibrary.org/obo/NCIT_C40174) (Uterine Corpus Epithelioid Leiomyosarcoma))) 37.53%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40170](http://purl.obolibrary.org/obo/NCIT_C40170) (Uterine Corpus Diffuse Leiomyomatosis))) 37.53%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40168](http://purl.obolibrary.org/obo/NCIT_C40168) (Uterine Corpus Lipoleiomyoma))) 37.53%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40167](http://purl.obolibrary.org/obo/NCIT_C40167) (Uterine Corpus Bizarre Leiomyoma))) 37.53%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40166](http://purl.obolibrary.org/obo/NCIT_C40166) (Uterine Corpus Myxoid Leiomyoma))) 37.53%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40165](http://purl.obolibrary.org/obo/NCIT_C40165) (Uterine Corpus Apoplectic Leiomyoma))) 37.53%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40164](http://purl.obolibrary.org/obo/NCIT_C40164) (Uterine Corpus Epithelioid Leiomyoma))) 37.53%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40163](http://purl.obolibrary.org/obo/NCIT_C40163) (Uterine Corpus Cellular Leiomyoma))) 37.53%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40162](http://purl.obolibrary.org/obo/NCIT_C40162) (Uterine Corpus Leiomyoma, Mitotically Active Variant))) 37.53%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40161](http://purl.obolibrary.org/obo/NCIT_C40161) (JAZF1-SUZ12 Fusion Protein Expression))) 37.53%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40160](http://purl.obolibrary.org/obo/NCIT_C40160) (t(7;17)(p15;q21)))) 37.53%


